DISCOVER Study Finds New Dual NRTI Pill Noninferior to Current Combo
A study shows Descovy for PrEP demonstrated that the treatment was non-inferior to Truvada for HIV prevention.
All articles by Diana Ernst, RPh
Adacel Approved for Repeat Vaccination Against Tetanus, Diphtheria, Pertussis
The approval was based on data from the Td537 study which included individuals 18-64 years old who had received a dose of Adacel 8-12 years prior (N=1330).
Supply Updates Announced for Recombivax HBV Vaccines
The information, posted to the Food and Drug Administration (FDA) website, states that both the Recombivax HB adult (10mcg/mL) and dialysis (40mcg/mL) formulations are not expected to be available in 2019.
SGLT2 Inhibitors and Urinary Tract Infections: What’s the Link?
For this study, the authors identified randomized controlled trials that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.
FDA Approves New Treatment for Travelers’ Diarrhea
Aemcolo is a broad spectrum, semi-synthetic, orally-administered, minimally-absorbed antibiotic designed to allow for delayed release to the colon.
Afluria, Afluria Quadrivalent Approved for Use in Patients 6 Months and Older
The vaccines are indicated for active immunization against influenza disease caused by virus subtypes A and type B present in the vaccine.
First-in-Class Antiviral Approved for the Treatment of Influenza
“This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years,” said FDA Commissioner Scott Gottlieb, MD.
Patient Develops Glandular Tularemia After Taking Care of Sick Cat
The 68-year-old patient reported having a fever for 1 week followed by progressive, painful swelling on the right side of his neck for 2 months.
Omadacycline Approved for Community-Acquired Bacterial Pneumonia, Skin Infections
The approval was based on Phase 3 data from 2 studies in ABSSSI, where treatment with Nuzyra was compared with linezolid, and 1 study in CABP comparing Nuzyra with moxifloxacin. Across all 3 trials, Nuzyra was found to be effective and generally safe and well-tolerated.
Amikacin Inhalation Suspension Approved for Mycobaterium Avium Infection
Arikayce is intended for oral inhalation use and is administered via the Lamira Nebulizer System only.
Next post in Antibiotics, Antimicrobial Resistance
